An update from Impedimed Limited ( (AU:IPD) ) is now available.
Impedimed Limited announced the cessation of certain securities, including 4,362,750 options that expired without exercise and 201,962 performance rights that lapsed due to unmet conditions as of March 31, 2025. This announcement may impact the company’s capital structure and could influence investor perceptions regarding the company’s financial management and strategic direction.
More about Impedimed Limited
Impedimed Limited operates in the medical technology industry, focusing on developing and providing non-invasive medical devices. The company’s primary products are designed to measure, monitor, and manage fluid status and body composition, with a significant market focus on healthcare providers and patients requiring precise fluid management solutions.
YTD Price Performance: -50.0%
Average Trading Volume: 57,724
Technical Sentiment Signal: Buy
Current Market Cap: $52.25M
See more insights into IPD stock on TipRanks’ Stock Analysis page.